BUSINESS
COMMENT-The US-China trade war has no winners, and markets will have to live with it
This is a war without a cease-fire in sight. This is a fact global markets will have to digest.
BUSINESS
RPG Life Sciences – Track for the long term
The management medium term goal of Rs 1,000 crore turnover by FY22 looks like a tall task now
BUSINESS
Credit growth improved in FY18 – who did it benefit?
For every additional Rs 100 of deposits in the banking system, Rs 55 is attracted by the 15 private banks and Rs 45 goes to the 21 public sector banks
BUSINESS
FY18 a good year for vehicle financing NBFCs – more steam left?
Should the headwinds lead to a correction in stocks, investors should look at some of the strong NBFCs
BUSINESS
Why creating a 'bad bank' is a better idea than simply throwing money at PSBs
Sweden, Finland and Ireland have all used bad banks to help end financial crises. In Asia, South Korea and China had resorted to creation of bad banks as well
BUSINESS
Luggage companies had a stellar run – what should you do now?
Although the medium to long-term outlook is extremely positive and the companies do not really see a problem in growing their revenue, investors got to keep in mind the pressure to near-term earnings especially in the context of the valuation.
BUSINESS
COMMENT: Rate hike removes event risk, markets should welcome 'neutral' stance
The rate hike removes a key event risk from the market and the front-loading of the action should help rein in inflationary expectations without upsetting the green shoots of recovery.
BUSINESS
COMMENT | Wary of trampling on green shoots, RBI may tiptoe to August before hiking rates
While inflationary pressure beckons attention, our fragile economic growth warrants nurturing.
EARNINGS
COMMENT-Q4 results show silver linings in several sectors, marred by large banking sector cloud
Invest in businesses where there is decent earnings visibility coupled with valuation comfort.
BUSINESS
VA Tech Wabag – difficult FY18 but promising long-term outlook available at a decent valuation
While the stock performance in the near-term is largely contingent on resolving the receivable issue and traction in large orders, we see limited downside and significant upside
BUSINESS
Karur Vysya Bank – small but getting smarter with end of asset quality woes near
While Q1 FY19 is likely to be another soft quarter for KVB, we are building in a revival in the second half of FY19. At 1.1 times book and 1.4 times adjusted book of FY19, the consolidation phase offers a great opportunity to accumulate this stock for the long term.
BUSINESS
COMMENT-Heeding Krugman's call to focus on manufacturing is key to Rising India
Conventional economic theory suggests that when an economy progresses, it passes from being predominantly agrarian to having a preponderance of manufacturing, and then becomes services-driven as it attains maturity.
MONEYCONTROL-RESEARCH
HDFC Bank and Kotak Mahindra Bank — The haloed duo with a long, promising road ahead
Investors got to stay invested in these stocks despite despite the optically expensive valuation.
BUSINESS
Can equities remain indifferent to the rise in bond yields?
Market experts feel that it is only a matter of time before the stock market reacts to the surge in bond yields.
BUSINESS
Hawkins – slow and steady, can it win the race?
With “election” the buzzword for 2018, discretionary consumption will be in focus. In this context, a core consumption play like Hawkins Cooker (CMP: Rs 3169, M Cap: Rs 1676 crore) merits attention.
BUSINESS
Housing finance companies: Selective bets emerging amid cautious stance
Even as near-term outlook remains cloudy for housing finance companies, some stocks deserve a closer look.
BUSINESS
FRDI or not – the winds of change will create big winners
The need for a strong resolution mechanism, different from regulation, was necessitated by the 2008 global financial crisis. Since modern financial system is highly interconnected, failure in any one sector can have a domino effect and rattle the system as a whole.
BUSINESS
Why should you buy Federal Bank now?
This middle-of-the-road mid-sized entity under the new savvy management has by and large crossed the asset quality problem. It has recently raised capital and looks set to accelerate growth.
INDIA
A rate hike could be less than a year away, so cut exposure to leveraged companies
The notorious combination of falling growth and rising prices commonly referred to as a stagflation usually hamstrings central banks.
BUSINESS
Jenburkt Pharma: A steady performer in the smallcap space
While the Q1 FY18 performance was disappointing, performance has improved sharply in the quarter gone by. We derive valuation comfort given the steady track record of profitability and superior return ratios.
BUSINESS
Why the Equitas stock is near the bottom, and may be worth a look
We expect FY19 to be a year of recovery post the dip in FY18. The bank is well capitalised (CAR 34.3 percent) and will not be constrained by capital to grow once it puts its house in order.
BUSINESS
Looking past the RBI's status quo: Are there signs the rate cut cycle is ending?
What was loud and clear was the RBI’s stance on future rates – at least in the foreseeable future, there is no possibility of a rate cut; depending on the inflation trajectory, one shouldn’t be surprised if the next move is a rate increase.
BUSINESS
Should minority shareholders be excited about the new Infosys boss?
While the near-term guidance is still muted and lower than the industry, the management change and payout policy should limit downside in the stock, making it a candidate to accumulate on weakness.
BUSINESS
Mangalam Drugs & Organics – valuation comfort for this small cap
For a company on a turnaround journey where the return ratios have started looking up meaningfully, the undemanding valuation at 9X FY19 projected earnings should be looked at seriously by investors
